# Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels

> **NCT00851370** · PHASE2 · WITHDRAWN · sponsor: **National Jewish Health**

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Omalizumab (Xolair)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00851370
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to find eligible subjects- study closed
- **Last updated:** 2017-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851370, "Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00851370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*